CoChat

Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome

Liu, Xin, Zhang, Ying, Zheng, Si‐yuan, Lin, Rong, Xie, Yi‐juan, Chen, Hui, Zheng, Yong‐xiong, Liu, En, Chen, Lin, Yan, Jia‐he, Xu, Wei, Mai, Ting‐ting, Gong, Yi · 2017 · Clinical Endocrinology
Cited by 148

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Summary: Context: Weight loss remains one of the most important arms in obese patients with polycystic ovary syndrome (PCOS). Further studies are needed to identify the best treatment. Objective: To evaluate the effects of exenatide (EXE) on reproductive and metabolic function in overweight/obese (OW/OB) PCOS. Design: This is a 24‐week open‐label prospective, randomized, clinical study. Patients and Measurements: This study randomized 176 OW/OB women diagnosed with PCOS to receive either EXE 10 μg BID (n = 88) or metformin (MET) 1000 mg BID (n = 88) for the first 12 weeks. Then all patients were treated with MET alone during the second 12 weeks. We observed metabolic parameters at 0 and 12 weeks, and then tracked the rate of pregnancy during the second 12 weeks. Results: After the first 12 weeks of intervention, compared with MET, subjects who received EXE had significantly decreased weight (4.29 ± 1.29 kg vs 2.28 ± 0.55 kg, P < .001) and total fat% (4.67 ± 0.09% vs 1.11 ± 0.32%, P < .001), improved the homeostasis model of assessment for insulin resistance (1.30 ± 0.58 vs 0.59 ± 0.12, P < .001) and increased the menstrual frequency ratio (0.62 ± 0.12 vs 0.37 ± 0.01, P < .001). During the second 12 weeks, the rate of natural pregnancy of EXE‐treated patients was significantly higher than MET‐treated patients (43.60% vs 18.70%, P < .05). Conclusions: Short‐term EXE therapy was linked to significant weight loss and central adiposity reduction, which may further explain the improvements in insulin resistance, inflammatory marker and menstrual cycle, which may contribute to increasing pregnancy rates in OW/OB women with PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.13454

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 22

  1. 10.1016/j.bpobgyn.2004.05.005 · DOI
  2. 10.1093/oxfordjournals.humrep.a019512 · DOI · Paper page
  3. 10.1210/jc.2004-2283 · DOI · Paper page
  4. Tang‐Christensen M, 1996, Central administration of GLP‐1‐(7‐36) amide inhibits food and water intake in rats, Am J Physiol, 271, R848
  5. 10.1210/endo.140.11.7143 · DOI · Paper page
  6. 10.1159/000446951 · DOI
  7. 10.2337/dc06-0864 · DOI
  8. 10.1016/j.obmed.2017.06.003 · DOI
  9. Huang Zhaosui LLY, 2015, Efficacy of liraglutide on metabolic parameters and pregnancy in polycystic ovary syndrome patients combined with impaired glucose tolerance and obesity, Chin J Diabetes Mellitus, 7, 437
  10. 10.1530/EJE-13-0797 · DOI · Paper page
  11. 10.1080/gye.15.2.142.149 · doi:10.1080/gye.15.2.142.149 · Paper page
  12. 10.1210/jc.80.4.1283 · doi:10.1210/jc.80.4.1283
  13. 10.1210/jc.2002-021688 · DOI · Paper page
  14. 10.1530/REP-09-0568 · DOI · Paper page
  15. 10.1097/GCO.0b013e32832aee96 · DOI
  16. 10.1016/j.soard.2005.02.008 · DOI · Paper page
  17. 10.1016/S1472-6483(10)61179-0 · DOI
  18. 10.1210/er.2014-1020 · DOI · Paper page
  19. 10.1161/CIRCHEARTFAILURE.112.000115 · DOI
  20. 10.1093/humrep/deh609 · DOI · Paper page
  21. Sangraula H, 2009, Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome, JNMA J Nepal Med Assoc, 48, 335
  22. 10.1016/j.ecl.2015.07.006 · DOI

Cited by

See all 148

Metadata

Authors
Liu, X., Zhang, Y., Zheng, S., Lin, R., Xie, Y., Chen, H., Zheng, Y., Liu, E., Chen, L., Yan, J., Xu, W., Mai, T., & Gong, Y.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2017-09-13
Volume
87
Issue
6
Pages
767-774
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2747812115
Cited by
148
References
13
FWCI
4.87
Type
journal article
Language
en
Open access
closed
Funders
National Natural Science Foundation of China (No. 81200607)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome. https://app.cochat.ai/papers/10.1111/cen.13454
The paper
Liu, X., Zhang, Y., Zheng, S., Lin, R., Xie, Y., Chen, H., Zheng, Y., Liu, E., Chen, L., Yan, J., Xu, W., Mai, T., & Gong, Y. (2017). Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome. Clinical Endocrinology. https://doi.org/10.1111/cen.13454

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.